| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.0089 | 0.8 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.0098 | 0.8 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.8 |
| mRNA | Sorafenib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |